Re-engineering the immune system
Exploiting an alpaca-derived single domain antibody fragment (VHH) to create distinct platform technologies for immune modulation.
Cerberus Therapeutics is a platform company developing innovative immunological solutions for antigen specific tolerance and infectious diseases. Unlike traditional approaches that rely on suppressing immune responses or simply targeting immunogenic regions of the pathogens, our pioneering technology empowers the system to engage its own broad and complex network, leading the immune system to re-wire itself.